Then we injected HLF-shSNHG14, HLF-shSNHG14-SSR2 cells and control cells subcutaneously in the flank of nude mice to evaluate the effect of SSR2 on HCC tumorigenicity. Here, SSR2 is linked to hepatocellular carcinoma.